CAPUTO, Antonella
 Distribuzione geografica
Continente #
NA - Nord America 6.825
EU - Europa 3.254
AS - Asia 1.505
OC - Oceania 4
AF - Africa 3
Continente sconosciuto - Info sul continente non disponibili 3
SA - Sud America 1
Totale 11.595
Nazione #
US - Stati Uniti d'America 6.805
PL - Polonia 1.724
CN - Cina 729
IT - Italia 415
UA - Ucraina 401
SG - Singapore 366
TR - Turchia 293
DE - Germania 266
GB - Regno Unito 163
SE - Svezia 87
FI - Finlandia 84
ID - Indonesia 52
BE - Belgio 35
VN - Vietnam 34
CA - Canada 20
RU - Federazione Russa 19
CZ - Repubblica Ceca 13
NL - Olanda 12
FR - Francia 11
IN - India 11
IR - Iran 8
LT - Lituania 8
RO - Romania 7
IE - Irlanda 6
HK - Hong Kong 5
AU - Australia 3
A2 - ???statistics.table.value.countryCode.A2??? 2
ZA - Sudafrica 2
AE - Emirati Arabi Uniti 1
AT - Austria 1
BD - Bangladesh 1
BR - Brasile 1
CH - Svizzera 1
EG - Egitto 1
EU - Europa 1
HU - Ungheria 1
IL - Israele 1
LK - Sri Lanka 1
MN - Mongolia 1
NZ - Nuova Zelanda 1
OM - Oman 1
PH - Filippine 1
Totale 11.595
Città #
Warsaw 1.724
Fairfield 948
Woodbridge 759
Houston 549
Ashburn 453
Santa Clara 406
Jacksonville 401
Chandler 369
Seattle 367
Ann Arbor 342
Wilmington 341
Cambridge 328
Singapore 291
Izmir 237
Ferrara 180
Princeton 173
Beijing 163
Nanjing 161
San Diego 107
New York 101
Shanghai 62
Jakarta 52
Milan 49
Los Angeles 45
Boardman 42
Nanchang 41
Shenyang 37
Hebei 36
Bologna 35
Brussels 35
Dong Ket 34
Jiaxing 33
Tianjin 30
Changsha 28
Dearborn 27
Falls Church 24
London 22
Norwalk 22
Jinan 21
Mountain View 21
Helsinki 18
Orange 18
Redwood City 17
Rome 16
San Mateo 15
Kunming 14
Modena 14
Auburn Hills 12
Brno 12
Des Moines 12
Munich 12
Ningbo 12
Ottawa 11
Taizhou 10
Ferrara di Monte Baldo 9
Toronto 9
Washington 9
San Bonifacio 8
Ardabil 7
Leawood 7
Phoenix 7
Changchun 6
Dublin 6
Frankfurt am Main 6
Hangzhou 6
Lanzhou 6
Monmouth Junction 6
Zhengzhou 6
Addison 5
Augusta 5
Bremen 5
Philadelphia 5
Andover 4
Dronten 4
Guangzhou 4
Hong Kong 4
New Bedfont 4
Bucharest 3
Chicago 3
Easton 3
Fuzhou 3
Haikou 3
Novosibirsk 3
Prescot 3
Pune 3
Tappahannock 3
Amsterdam 2
Anzola 2
Arezzo 2
Berlin 2
Borgo Val di Taro 2
Brescia 2
Chengdu 2
Falkenstein 2
Gorle 2
Hendon 2
Hunedoara 2
Kilburn 2
Monza 2
North Bergen 2
Totale 9.482
Nome #
HIV-1 Tat protein modulates the generation of cytotoxic T cell epitopes by modifying proteasome composition and enzymatic activity 265
Identification of new HIV-1 Gag-specific cytotoxic T lymphocyte responses in BALB/c mice 259
BK virus-plasmid expression vector that persists episomally in human cells and shuttles into Escherichia coli 233
Biocompatible anionic polymeric microspheres as priming delivery system for effetive HIV/AIDS tat-based vaccines 218
Candidate HIV-1 Tat vaccine development: From basic science to clinical trials 218
HIV-1 tat addresses dendritic cells to induce a predominant th1-type adaptive immune response that appears prevalent in the asymptomatic stage of infection 216
The presence of anti-Tat antibodies is predictive of long-term nonprogression to AIDS or severe immunodeficiency: Findings in a cohort of HIV-1 seroconverters 207
Long-term protection against SHIV89.6P replication in HIV-1 Tat vaccinated cynomolgus monkeys 204
null 183
null 179
Systemic immunodominant CD8 responses with an effector-like phenotype are induced by intravaginal immunization with attenuated HSV vectors expressing HIV Tat and mediate protection against HSV infection 173
null 167
Nanoparticles for delivery of a pharmacologically active agent 163
The HIV-1 Tat protein induces the activation of CD8+ T cells and affects in vivo the magnitude and kinetics of antiviral responses. 161
Effects of different routes of administration on the immunogenicity of the Tat protein and a Tat-derived peptide 161
Recombinant herpes simplex virus and uses therefor 157
Cationic PMMA nanoparticles bind and deliver antisense oligoribonucleotides allowing restoration of dystrophin expression in the mdx mouse 152
The HIV-1 Tat protein affects human CD4+ T cell programming and activation, and favors the differentiation of naïve CD4+ T cells 137
An Attenuated Herpes Simplex Virus Type 1 (HSV1) Encoding the HIV-1 Tat Protein Protects Mice from a Deadly Mucosal HSV1 Challenge 136
Transformation of hamster kidney cells by fragments of BK virus DNA 129
The Tat protein broadens T cell responses directed to the HIV-1 antigens Gag and Env: Implications for the design of new vaccination strategies against AIDS 125
Morphological, histochemical, immunohistochemical, and ultrastructural characterization of tumors and dysplastic and non-neoplastic lesions arising in BK virus/tat transgenic mice 115
Cooperation in oncogenesis between BK virus early region gene and the activated human c-Harvey RAS oncogene 114
null 113
null 110
Transformation of human embryonic fibroblasts by BK virus, BK virus DNA and a subgenomic BK virus DNA fragment 110
Prevalence of liver tumours in HIV-1 tat-transgenic mice treated with urethane 108
Priming with a very low dose of DNA complexed with cationic block copolymers followed by protein boost elicits broad and long-lasting antigen-specific humoral and cellular responses in mice 107
Containment of infection in Tat vaccinated monkeys after rechallenge with a higher dose of SHIV89.6Pcy243 107
Antiangiogenic, antitumoural and antimetastatic effects of two distamycin A derivatives with anti-HIV-1 Tat activity in a Kaposi's sarcoma-like murine model 106
null 104
null 103
null 101
Episomal DNA of a BK virus variant in a human insulinoma 100
Adenovirus type 12 early region 1A proteins repress class I HLA expression in transformed human cells 100
High expression of exogenous cDNAs directed by HIV-1 long terminal repeat in human cells constitutively producing HIV-1 tat and adenovirus E1A/E1B 99
Recent Advances In The Development Of HIV-1 Tat-Based Vaccines 97
Inhibition of HIV-1 replication by a Tat transdominant negative mutant in human peripheral blood lymphocytes from healthy donors and HIV-1-infected patients 97
null 95
Age-related decline of de novo T cell responsiveness as a cause of COVID-19 severity 94
null 94
T.P.2.07 The systemic administration of a low dose of 2OMePS-AON combined with novel cationic polymethylmethacrylate nanoparticles induces the rescue of dystrophin expression in the mdx murine model 93
null 91
null 90
Complex associates of plasmid DNA and a novel class of block copolymers with PEG and cationic segments as new vectors for gene delivery 90
null 90
null 87
The human immunodeficiency virus type-1 Tat protein upregulates Bcl-2 gene expression in Jurkat T-cell lines and primary peripheral blood mononuclear cells 87
The Tat Protein of HIV-1 Prevents the Loss of HSV-Specific Memory Adaptive Responses and Favors the Control of Viral Reactivation 87
The HIV-1 regulatory genes tat and rev as targets for gene therapy 86
Preparation and characterization of innovative protein-coated poly(methylmethacrylate) core-shell nanoparticles for vaccine purposes. 86
null 86
null 85
null 83
Interferon regulatory factor-1 acts as a powerful adjuvant in tat DNA based vaccination 82
EFFECT OF TAT TRANSDOMINANT NEGATIVE MUTANTS ON HIV-1 REPLICATION IN JURKAT T-CELL LINES 81
null 81
The tat gene and protein of the human immunodeficiency virus type 1. 80
null 79
null 79
Expression of hepatitis B surface antigen in human cells by a recombinant BK virus DNA vector 76
null 75
Inhibition of HIV-1 replication and reactivation from latency by tat transdominant negative mutants in the cysteine rich region 74
Reexamination of the coding potential of the HTLV-1 pX region 74
DNA immunization with HIV-1 tat mutated in the transactivation domain induces humoral and cellular immune response against wild-type Tat 73
Transactivation of BKV and SV40 early promoters by BKV and SV40 T-antigens 73
null 72
Naïve CD8+ T-Cells Engage a Versatile Metabolic Program Upon Activation in Humans and Differ Energetically From Memory CD8+ T-Cells 71
Vaccination with DNA containing tat coding sequences and unmethylated CpG motifs protects cynomolgus monkeys upon infection with simian/human immunodeficiency virus (SHIV89.6P) 70
Inhibition of human immunodeficiency virus reactivation from latency by a tat transdominant negative mutant 69
New BK virus episomal vector for complementary DNA expression in human cells 69
Neutralizing and cross-neutralizing antibody titres induced by bivalent and quadrivalent human papillomavirus vaccines in the target population of organized vaccination programmes 69
Induction of anti-Tat immune response in mice following inoculation of plasmid DNA expressing HIV-tat mutant genes. 68
The HIV-1 tat gene as a target for gene therapy and analysis of its role in cell proliferation. 68
Transformation of Hamster kidney cells by a fragment of BK virus DNA containing the entire early region. 67
Core-shell microspheres by dispersion polymerization as promising delivery systems for proteins 67
Immobilized HIV-1 Tat protein promotes gene transfer via a transactivation-independent mechanism which requires binding of Tat to viral particles 66
Interaction of Sp1 transcription factor with HIV-1 Tat protein: Looking for cellular partners 66
Induzione di una risposta immune in topi immunizzati con DNA plasmidici codificanti due mutanti transdominanti negativi del gene tat di HIV-1. 65
Studies on the effect of the combined expression of anti-tat and anti-rev genes on HIV-1 replication 65
Micellar-type complexes of tailor-made synthetic block copolymers containing the HIV-1 tat DNA for vaccine application 65
In Chronic Hepatitis C Infection, Myeloid-Derived Suppressor Cell Accumulation and T Cell Dysfunctions Revert Partially and Late After Successful Direct-Acting Antiviral Treatment 65
Functional polymeric nano/microparticles for surface adsorption and delivery of protein and DNA vaccines 64
Formation of oligomeric free BK virus DNA is required for tandem integration of viral genomes into cellular DNA 63
The expression of P-glycoprotein is causally related to a less aggressive phenotype in human osteosarcoma cells 63
Modulation of Th1/Th2 immune responses to HIV-1 Tat by new pro-GSH molecules 62
Pentosan Polysulfate as an Inhibitor of Extracellular HIV-1 Tat 62
HIV-1 Tat-Based Vaccines: From Basic Science to Clinical Trials 61
The increase in intra-macrophage thiols induced by new pro-GSH molecules directs the Th1 skewing in ovalbumin immunized mice 60
The Sp1 transcription factor does not directly interact with the HIV-1 Tat protein 59
Presenza del virus BK in sarcomi di Kaposi. 56
Characterization of the effects of two polysulfonated distamycin A derivatives, PNU145156E and PNU153429, on HIV type 1 Tat protein 56
Oncogenicity of BK virus for immunosuppressed hamster 55
Hpv-specific systemic antibody responses and memory b cells are independently maintained up to 6 years and in a vaccine-specific manner following immunization with cervarix and gardasil in adolescent and young adult women in vaccination programs in Italy 54
Effects of the age of vaccination on the humoral responses to a human papillomavirus vaccine 54
HIV-1 Tat mutants in the cysteine-rich region down-regulate HLA class II expression in T lymphocytic and macrophage cell lines 51
Impaired Priming of SARS-CoV-2-Specific Naive CD8+ T Cells in Older Subjects 51
Studi sulle interrelazioni tra il virus BK e i tumori insulinari 50
null 50
null 49
Totale 10.087
Categoria #
all - tutte 58.494
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 1.824
Totale 60.318


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20201.629 0 0 0 0 0 278 262 269 238 332 159 91
2020/20211.767 165 150 142 156 111 153 109 219 72 237 157 96
2021/20221.319 38 111 73 82 29 53 68 114 61 115 106 469
2022/2023933 140 37 54 103 130 118 59 97 113 9 47 26
2023/2024644 63 80 33 23 44 143 25 36 20 17 11 149
2024/20251.051 91 70 240 100 332 218 0 0 0 0 0 0
Totale 11.830